BGI sequencing: based on BGI's proprietary DNBseqTM technology, MGISEQ-T7 is built with innovative quadruple flowcell staging that allows simultaneous but independent operation of 1 to 4 flowcells in a single run. The MGI proprietary DNBseqTM technology used in T7 delivers higher accuracy and improves efficiency through upgrades to the flowcell, fluid, and biochemical and optical system. A supercomputer for the life science industry, MGISEQ-T7 takes the production capacity of the sequencer to a new level with daily output of data up to 6Tb.
BGI sequencing: based on BGI's proprietary DNBseqTM technology, MGISEQ-2000 Genetic Sequencer - Versatility to satisfy multiple needs
BGI sequencing: based on BGI's proprietary DNBseqTM technology, MGISEQ-200 is a miniature sequencer that transcends geographical restrictions. MGISEQ-200 Genetic Sequencer - Our Most Accessible Sequencer for You
DNBseqTM technology combines the power of DNA Nanoballs (DNB™), PCR-free Rolling Circle Replication, Patterned Nano Arrays and cPAS to deliver a new level of data clarity and affordability. The combination of linear ampliﬁcation and DNB technology reduces the error rate while enhancing the signal, resulting in real advantages. For more detail on BGI's proprietary sequencing technology and sequencers please visit here.